Lazo-Langner A, Louzada M, Garg A, et al. Assessing the risk-benefit of anticoagulants in elkderly patients with cancer-associated venous thromboembolism; a population based study. EHA 2017, abstract S441.
Rituximab voor primair CZS-lymfoom lijkt niet nuttig
sep 2018 | Lymfoom